Educational protocol hub
MOTS-C: protocol variants and reconstitution resources
Educational hub for MOTS-C, grouping 5 available protocol variants with links to the exact dosage and reconstitution pages.
What this hub covers
This page groups the available MOTS-C protocol variants so readers can choose the exact vial-size guide without mixing formats.
Reconstitution workflow
Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.
Research-only context
All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.
Available protocol variants
Choose the exact guide you want to view.
MOTS-C
MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) studied as a metabolic regulator via AMPK activation. Research sources report subcutaneous administration of 200 mcg to 1 mg, once daily, increased gradually.
View protocolMOTS-C
MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) studied as a metabolic regulator via AMPK activation. Research sources report subcutaneous administration of 200 mcg to 1 mg, once daily, increased gradually.
View protocolMOTS-C
MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) studied as a metabolic regulator via AMPK activation. Research sources report subcutaneous administration of 200 mcg to 1 mg, once daily, increased gradually.
View protocolMOTS-C
MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) studied as a metabolic regulator via AMPK activation. Research sources report subcutaneous administration of 200 mcg to 1 mg, once daily, increased gradually.
View protocolMOTS-c
MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) studied as a metabolic regulator via AMPK activation. Research sources report subcutaneous administration of 200 mcg to 1 mg, once daily, increased gradually.
View protocolRelated research resources
Internal links that help readers and search engines understand this peptide topic cluster.
References
- Cell Metabolism (2015) — MOTS-c promotes metabolic homeostasis, reduces obesity and insulin resistance
View Source - J Translational Medicine (2023) — MOTS-c: effects and mechanisms of stress, metabolism, and aging
View Source - J Mol Medicine (2019) — MOTS-c regulates lipid homeostasis in an ovariectomy model
View Source - Nature Communications (2021) — MOTS-c regulator of age-related physical decline and muscle homeostasis
View Source - USADA Spirit of Sport (2023) — What is the MOTS-c peptide?
View Source - Kim SJ et al. J Mol Med (Berl) 2019 — MOTS-c: an equal opportunity insulin sensitizer.
View Source - Zhai D et al. Mol Immunol 2017 — MOTS-c peptide increases survival and decreases bacterial load in mice infected with MRSA.
View Source - Kim SJ et al. Geroscience 2021 — Mitochondrial-derived peptides in aging and age-related diseases.
View Source - Ming W et al. Biochem Biophys Res Commun 2016 — Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation.
View Source - D'Souza RF et al. Aging (Albany NY) 2020 — Increased expression of the mitochondrial derived peptide, MOTS-c, in skeletal muscle of healthy aging men is associated with myofiber composition.
View Source - Cell Metabolism — MOTS-c: a mitochondrial-derived regulator of metabolism
View Source - Wan W et al. J Transl Med 2023 — Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging.
View Source
Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.